| Targeted therapy and immunotherapy in early-stage non-small cell lung cancer: current evidence and ongoing trials M de Scordilli, A Michelotti, E Bertoli, E De Carlo, A Del Conte, A Bearz International journal of molecular sciences 23 (13), 7222, 2022 | 53 | 2022 |
| NAFLD-related hepatocarcinoma: the malignant side of metabolic syndrome A Michelotti, M de Scordilli, L Palmero, M Guardascione, M Masala, ... Cells 10 (8), 2034, 2021 | 36 | 2021 |
| NSCLC as the paradigm of precision medicine at its finest: the rise of new druggable molecular targets for advanced disease A Michelotti, M de Scordilli, E Bertoli, E De Carlo, A Del Conte, A Bearz International Journal of Molecular Sciences 23 (12), 6748, 2022 | 23 | 2022 |
| Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: A pilot study in … S Albani, B Pinamonti, T Giovinazzo, M de Scordilli, E Fabris, D Stolfo, ... The International Journal of Cardiovascular Imaging 36, 1213-1225, 2020 | 23 | 2020 |
| Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva M Bartoletti, R Mazzeo, M De Scordilli, A Del Fabro, MG Vitale, L Bortot, ... International Journal of Gynecologic Cancer 30 (11), 2020 | 17 | 2020 |
| Reliability of noninvasive hemodynamic assessment with Doppler echocardiography: comparison with the invasive evaluation M de Scordilli, B Pinamonti, S Albani, C Gregorio, G Barbati, C Daneluzzi, ... Journal of cardiovascular medicine 20 (10), 682-690, 2019 | 16 | 2019 |
| Liquid biopsy in colorectal cancer: Onward and upward S Torresan, M de Scordilli, M Bortolot, P Di Nardo, L Foltran, A Fumagalli, ... Critical Reviews in Oncology/Hematology 194, 104242, 2024 | 8 | 2024 |
| Preoperative treatments in borderline resectable and locally advanced pancreatic cancer: Current evidence and new perspectives M de Scordilli, A Michelotti, D Zara, L Palmero, M Alberti, C Noto, F Totaro, ... Critical Reviews in Oncology/Hematology 186, 104013, 2023 | 6 | 2023 |
| LDH as prognostic factor in second line treatment for advanced gastric cancer: The LINE study. A Michelotti, M de Scordilli, E Sperti, R Mazzeo, C Corvaja, G Aimar, ... Journal of Clinical Oncology 39 (15_suppl), e16102-e16102, 2021 | 3 | 2021 |
| Prognostic role of macrophage infiltration and monocyte-to-lymphocyte ratio in stage III colon cancer: The MIRROR study. D Basile, M Polano, S Buriolla, C Gallois, F Cortiula, C Corvaja, ... Journal of Clinical Oncology 38 (15_suppl), e16118-e16118, 2020 | 1 | 2020 |
| Safety and efficacy of intensified preoperative management of locally advanced gastrorsophageal junction cancer (INPROVE). S Torresan, M Bortolot, M de Scordilli, R Innocente, A Fumagalli, L Foltran, ... Journal of Clinical Oncology 42 (16_suppl), e16110-e16110, 2024 | | 2024 |
| Triplet chemotherapy combined with anti-EGFR treatment in RAS wild-type colon cancer: A network meta-analysis. P Di Nardo, F Giudici, D Basile, M de Scordilli, S Torresan, M Bortolot, ... Journal of Clinical Oncology 42 (16_suppl), e15592-e15592, 2024 | | 2024 |
| Chemotherapy with or without surgery for locally advanced or borderline resectable pancreatic ductal adenocarcinoma: A retrospective multicenter international study. M Venerito, D Zhang, S Becht, J Schütz, CD Steup, US Bankstahl, ... Journal of Clinical Oncology 42 (16_suppl), e16352-e16352, 2024 | | 2024 |
| 2119P The prognostic impact of nutritional assessment and scores in advanced gastric cancer S Torresan, M De Scordilli, G Bortolus, M Bortolot, G Zapelloni, R Mazzeo, ... Annals of Oncology 34, S1108, 2023 | | 2023 |
| 876P An observational retrospective study on microsatellite instability (MSI) in metastatic melanoma G Targato, E Poletto, S Buriolla, M de Scordilli, F Pravisano, G Pascoletti, ... Annals of Oncology 33, S949, 2022 | | 2022 |
| 249P A retrospective analysis on capecitabine and vinorelbine combination in metastatic breast cancer: The MARCELLINO study M de Scordilli, L Bortot, L Cucciniello, F Totaro, R Mazzeo, M Alberti, ... Annals of Oncology 33, S650, 2022 | | 2022 |
| Breast cancer incidence in patients with BRCA-related advanced ovarian cancer receiving olaparib-based maintenance therapy: A pooled analysis from phase III … M Bartoletti, M Montico, R Mazzeo, M De Scordilli, L Musacchio, E Lucia, ... Journal of Clinical Oncology 40 (16_suppl), 5566-5566, 2022 | | 2022 |
| 297 Echocardiographic biventricular coupling index to predict pre-capillary pulmonary hypertension S Albani, D Stolfo, A Venkateshvaran, V Chubuchny, M De Scordilli, ... European Heart Journal Supplements 23 (Supplement_G), suab132. 037, 2021 | | 2021 |
| 800P Tailoring adjuvant treatments in high-risk early stage endometrial cancer: Clinical outcomes of sequential chemoradiation in a real-word scenario M de Scordilli, M Bartoletti, E Palazzari, R Mazzeo, A Michelotti, M Alberti, ... Annals of Oncology 32, S762, 2021 | | 2021 |
| 842P Carboplatin-induced thrombocytopenia in ovarian cancer: A focus on predictive factors R Mazzeo, M Bartoletti, M de Scordilli, M Alberti, A Michelotti, C Lisanti, ... Annals of Oncology 31, S631, 2020 | | 2020 |
